Morselized Cadaveric Tissue Composition for Wound Healing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current wound treatments derived from cadaveric components lack superior efficacy and improved outcomes, necessitating a more effective healing cascade promotion.
Innovation Solution
A wound treatment composition comprising morselized cadaveric muscle, skin, and adipose tissue, with added stem cells, cytokines, and antimicrobial agents, formulated as a viscous paste or putty for direct application or injection into wounds, promoting vascularization and tissue regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional cadaveric wound treatments are used, then basic wound coverage is provided, but superior efficacy and improved healing outcomes are not achieved
Solution Approach 1:
The patent employs composite materials by combining multiple tissue types (muscle, skin, adipose) with different functional properties into a single wound treatment composition. This composite approach provides superior healing outcomes by integrating structural support, cellular components, and biochemical factors from each tissue type, while the pre-combined formulation manages complexity through standardized manufacturing processes
Solution Approach 2:
The patent applies segmentation by dividing the wound treatment into distinct functional components (morselized muscle tissue for structural framework, skin tissue for epithelial regeneration, adipose tissue for cushioning and stem cell reservoir) that work synergistically. This segmentation allows each component to contribute its specialized function while achieving superior overall healing efficacy
2Productivity
If morselized cadaveric tissue composition is used, then accelerated wound healing and vascularization are promoted, but manufacturing process complexity increases
Solution Approach 1:
The patent applies preliminary action by pre-processing cadaveric tissues through decellularization, morselization, and combination into a ready-to-use composition before clinical application. This pre-preparation accelerates the healing process when applied to wounds, while the standardized pre-processing protocol manages manufacturing complexity through established procedures
Solution Approach 2:
The patent utilizes parameter changes by transforming cadaveric tissue through controlled decellularization (removing cellular material while preserving extracellular matrix), morselization (size reduction to specific particle dimensions), and formulation (achieving optimal viscosity and flow properties). These parameter transformations enhance healing speed while the controlled processes manage manufacturing complexity
3Reliability
If multiple tissue components are combined in viscous formulation, then bioactive matrix for healing cascade is provided, but formulation complexity and viscosity control become challenging
Solution Approach 1:
The patent applies parameter changes by carefully controlling the physical and chemical parameters of the formulation, including viscosity, flow properties, and compositional ratios of different tissue types. These parameter optimizations ensure the composition provides an effective bioactive matrix for healing while maintaining manageable formulation characteristics for clinical application
Solution Approach 2:
The patent uses composite materials by formulating a multi-component mixture of morselized muscle, skin, and adipose tissues that create a synergistic bioactive matrix. This composite formulation enhances healing efficacy through the combined contributions of each tissue type, while the integrated formulation approach manages complexity through standardized preparation protocols
Data Source
AI summary
Wound treatment compositions obtained from cadaveric tissues are provided. Methods of processing such tissues to form wound treatment compositions are provided. Methods of treating a wound are also provided.